Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Duke Energy
DUK
|
+$172M |
| 2 |
Chevron
CVX
|
+$99.4M |
| 3 |
Apple
AAPL
|
+$91.7M |
| 4 |
Evergy
EVRG
|
+$89M |
| 5 |
Consolidated Edison
ED
|
+$86.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$412M |
| 2 |
Mondelez International
MDLZ
|
+$131M |
| 3 |
Johnson & Johnson
JNJ
|
+$107M |
| 4 |
NiSource
NI
|
+$88.5M |
| 5 |
PPL
PPL Corp
PPL
|
+$86.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.81% |
| 2 | Technology | 9.77% |
| 3 | Healthcare | 7.98% |
| 4 | Utilities | 7.37% |
| 5 | Real Estate | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Vera Bradley
VRA
$89.6M
| – | – |
-63,545
| Closed | -$347K |
|
2102
Verrica Pharmaceuticals
VRCA
$82.8M
| – | – |
-18,613
| Closed | -$270K |
|
2103
Vertiv
VRT
$101B
| – | – |
-152,574
| Closed | -$15.2M |
|
2104
Vishay Intertechnology
VSH
$4.85B
| – | – |
-135,248
| Closed | -$2.56M |
|
2105
CALL
Vistra
VST
$45.7B
| – | – |
-181,300
| Closed | -$21.5M |
|
2106
Verastem
VSTM
$624M
| – | – |
-72,061
| Closed | -$215K |
|
2107
CALL
Vestis
VSTS
$1.68B
| – | – |
-100,500
| Closed | -$1.5M |
|
|
2108
Vestis
VSTS
$1.68B
| – | – |
-334,213
| Closed | -$4.98M |
|
2109
VTEX
VTEX
$603M
| – | – |
-75,488
| Closed | -$562K |
|
2110
Bristow Group
VTOL
$1.34B
| – | – |
-15,344
| Closed | -$532K |
|
2111
Viatris
VTRS
$18.7B
| – | – |
-630,098
| Closed | -$7.32M |
|
2112
VirTra
VTSI
$35.4M
| – | – |
-11,087
| Closed | -$69K |
|
|
VTYX
2113
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-76,007
| Closed | -$166K |
|
2114
Waldencast
WALD
$167M
| – | – |
-45,613
| Closed | -$166K |
|
2115
Washington Trust Bancorp
WASH
$757M
| – | – |
-13,122
| Closed | -$423K |
|
2116
Walker & Dunlop
WD
$1.38B
| – | – |
-21,081
| Closed | -$2.4M |
|
2117
Workday
WDAY
$49.4B
| – | – |
-162,710
| Closed | -$39.8M |
|
2118
Western Digital
WDC
$166B
| – | – |
-44,317
| Closed | -$2.29M |
|
2119
Whirlpool
WHR
$2.63B
| – | – |
-17,967
| Closed | -$1.92M |
|
2120
Winmark
WINA
$1.24B
| – | – |
-1,842
| Closed | -$705K |
|
2121
Wingstop
WING
$3.14B
| – | – |
-20,208
| Closed | -$8.41M |
|
2122
Warner Music
WMG
$14.2B
| – | – |
-18,036
| Closed | -$565K |
|
|
WOW
2123
DELISTED
WideOpenWest
WOW
| – | – |
-258,011
| Closed | -$1.35M |
|
|
WSR
2124
DELISTED
Whitestone REIT
WSR
| – | – |
-18,791
| Closed | -$254K |
|
2125
Select Water Solutions
WTTR
$2.54B
| – | – |
-118,305
| Closed | -$1.32M |
|
Similar funds
Michael Gelband's Q4 2024 Portfolio in Review
As of Q4 2024, Michael Gelband held 2,201 positions worth $14.6B, down 11% from $16.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Michael Gelband withdrew a net $1.86B in Q4 2024, closing 764 positions and reducing 361 holdings. Its most notable exit was Mondelez International, an estimated $131M position sold in full.
By sector, the portfolio is most concentrated in Financials at 9.8% of assets, up from 4.6% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Michael Gelband opened a new position in Duke Energy worth $164M.
- Michael Gelband's largest Q4 2024 buy was Duke Energy: 1,520,504 shares worth $164M.
- Michael Gelband added most to Chevron in Q4 2024, an estimated $99.4M increase.
- Michael Gelband's biggest Q4 2024 reduction was Microsoft, cutting an estimated $412M.
- Michael Gelband fully exited Mondelez International in Q4 2024, selling an estimated $131M.
- Michael Gelband's ten largest holdings make up 34% of its $14.6B portfolio in Q4 2024.
- Michael Gelband opened 633 new positions and closed 764 in Q4 2024.
- Michael Gelband's portfolio value fell 11% quarter-over-quarter to $14.6B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.